UW-Madison, Madison, WI, USA.
Department of Pharmacy, Saint Vincent Hospital, Worcester, MA, USA.
Am J Health Syst Pharm. 2022 Sep 22;79(19):1663-1673. doi: 10.1093/ajhp/zxac179.
A systematic review was performed to determine if remote stewardship (telestewardship) provides clinical and fiscal benefit and is a feasible alternative to local stewardship programs.
Antibiotic resistance is an increasingly important national and global threat. US regulators have made antimicrobial stewardship programs a condition of participation in federally funded healthcare programs, and stewardship programs are surveyed during accreditation visits. Small and rural hospitals are at risk for stewardship noncompliance because lack of resources limits comprehensive stewardship program implementation. Remote stewardship programs are established to remedy this area of partial compliance. To characterize the impact of remote stewardship on selected clinical and fiscal outcomes, PubMed was searched for studies involving telestewardship that reported data on antimicrobial utilization, patient length of stay, mortality, bacterial susceptibility, hospital-acquired Clostridioides difficile infection (HA-CDI), and/or antimicrobial costs. A systematic approach was used to screen study titles, abstracts, and content and data extracted. Study quality was analyzed using Cochrane risk-of-bias assessment tools. Fourteen studies were included in the final review. Collectively, the antimicrobial utilization data was positive, with utilization of targeted antimicrobials decreasing after telestewardship implementation. Mixed (both positive and neutral) results were found for patient length of stay, mortality, and HA-CDI rates. Fiscal outcomes were consistently positive.
Based on the reviewed evidence, remote antimicrobial stewardship programs may aid in the more judicious use of antimicrobials by decreasing utilization rates. More studies are needed to clarify patient-oriented outcomes. Telestewardship has positive effects in terms of cost savings, although savings may be offset by the structure of the program.
系统评价旨在确定远程监管(远程监管)是否能提供临床和财政效益,以及是否可以作为本地监管计划的可行替代方案。
抗生素耐药性是一个日益严重的国家和全球威胁。美国监管机构已将抗菌药物管理计划作为参与联邦资助医疗保健计划的条件,并在认证访问期间对其进行调查。由于资源匮乏限制了全面的管理计划实施,小型和农村医院面临着管理计划不合规的风险。远程管理计划的建立是为了弥补这一合规性不足的问题。为了描述远程管理对选定的临床和财政结果的影响,在 PubMed 上搜索了涉及远程监管的研究,这些研究报告了抗菌药物使用、患者住院时间、死亡率、细菌耐药性、医院获得性艰难梭菌感染(HA-CDI)和/或抗菌药物成本的数据。采用系统方法筛选研究标题、摘要和内容,并提取数据。使用 Cochrane 偏倚风险评估工具分析研究质量。最终审查共纳入了 14 项研究。总体而言,抗菌药物使用数据呈阳性,远程监管实施后,目标抗菌药物的使用量减少。患者住院时间、死亡率和 HA-CDI 发生率的结果则较为混杂(既有阳性结果,也有中性结果)。财政结果始终呈阳性。
基于已审查的证据,远程抗菌药物管理计划可能有助于通过降低使用率来更合理地使用抗菌药物。需要更多的研究来阐明以患者为中心的结果。远程监管在节省成本方面具有积极影响,尽管节省的成本可能会因计划的结构而抵消。